Outlook Therapeutics

$1.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-2.42%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell OTLK and other stocks, options, and ETFs commission-free!

About OTLK

Outlook Therapeutics, Inc. Common Stock, also called Outlook Therapeutics, is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ. The listed name for OTLK is Outlook Therapeutics, Inc. Common Stock.

CEO
Lawrence A. Kenyon
Employees
14
Headquarters
South Brunswick, New Jersey
Founded
2010
Market Cap
153.89M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.50M
High Today
$1.31
Low Today
$1.20
Open Price
$1.27
Volume
932.29K
52 Week High
$1.74
52 Week Low
$0.499

Collections

OTLK Earnings

-$0.62
-$0.40
-$0.17
$0.05
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Dec 17, Pre-Market

You May Also Like